Dietary intake by patients taking GLP-1 and dual GIP/GLP-1 receptor agonists: A narrative review and discussion of research needs. In Obesity Pillars (p. 100121).

The review authors noted that research into the potential brain benefits of GLP-1 medications needs more research but are optimistic about the future of these drugs in how they may boost brain health.

GLP-1-based drugs like Novo Nordisk’s Ozempic and Wegovy and Eli Lilly’s Mounjaro and Zepbound have exploded in demand for helping people lose unprecedented amounts of weight.

GLP-1 analogues, such as semaglutide, are prescribed for people with type 2 diabetes, including those with the condition who have obesity, in order to promote weight loss and improve control of ...

Glucagon-like peptide-1 (GLP-1) receptor agonists, including those targeting additional pathways, help otherwise healthy people without diabetes shed pounds, albeit at the cost of some side effects, a ...

At Healthline, we take choosing which online GLP-1 providers to feature in our content very seriously. Keep reading to learn more about how we vet these platforms and what we look for when ...

Question: How do you both view the future of the GLP-1 market and Amazon Pharmacy’s place within it? John Love: The launch of GLP-1s for the application of obesity has been messy and bad for ...

To understand how GLP-1 Daily aims to work, it’s crucial to review the science behind GLP-1 medications. Prescription GLP-1 drugs like Ozempic function by mimicking the effects of the natural ...